Skip to content
Fiscal Receipts

Senate LDA lobbying filing

MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS

Registrant: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP) Year: 2025 Period: First Quarter Type: Q1

View on lda.senate.gov ↗

Reported income

not reported

Reported expenses

$1.22M

Tracked program mentions2

Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.

  • Emergency Management Modernization Program9666BU8000matched: “Emergency|Modernizationmatched 2+ title words

    Equitable Community Access to Pharmacist Services Act; Clinical trial diversity, health equity; Emergency preparedness…

  • Making, Maintaining, Supply Chain and Logistics0602025Ematched: “Supply|Chainmatched 2+ title words

    Equitable Community Access to Pharmacist Services Act; Clinical trial diversity, health equity; Emergency preparedness…

Lobbying activities5

  • Health IssuesHCR

    Equitable Community Access to Pharmacist Services Act; Clinical trial diversity, health equity; Emergency preparedness and response. PAHPA Reauthorization; Healthcare innovation, ARPA-H, oncology research; Community Health Center Reauthorization; Benefit cost and transparency, real time benefit tools and patient APIs - S. 1339; Controlled Substance Reporting; Pharmaceutical Manufacturing and Supply Chain Shortage; Alleviating Drug Shortages; Telehealth Modernization Act of 2024; H.R.4011 Timely Access to Cancer Treatment Act; H.R.2630, S.652 The Safe Step Act; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3561, PATIENT Act; H.R. 4473, Medicare Patient Access to Cancer Treatment Act; HR 2484 Seniors Access to Critical Medications Act.

  • Medicare/MedicaidMMM

    Equitable Community Access to Pharmacist Services Act; Healthcare innovation and oncology research; H.R.3173, S.3018 The Improving Seniors Timely Access to Care Act; Medically integrated physician dispensing regulations; HR 2484 Seniors Access to Critical Medications Act

  • PharmacyPHA

    Equitable Community Access to Pharmacist Services Act; H.R. 4011 Timely Access to Cancer Treatment; Medically integrated physician dispensing regulations; S.127, PBM Transparency Act; Drug price transparency and cost savings opportunities.

  • Tariff (miscellaneous tariff bills)TAR

    H.R.5376 The Inflation Reduction Act

  • Taxation/Internal Revenue CodeTAX

    Last-in, first-out (LIFO) Inventory Accounting Method; H.R.5376 The Inflation Reduction Act

Lobbyists7

  • BEN JONES
  • BRIAN BRANTONrevolving door

    Chief of Staff, Congressman Polis; Chief of Staff, Congressman Sestak; Legislative Director, Congressman Wu; Legislative Counsel, Congressman Holt; Legislative Assistant, Congresswoman Mink

  • DIANA FELNER
  • JASEY CARDENAS
  • JOSHUA BABB
  • MATTHEW WILLIAMS
  • RICHARD BUCKLEY

Source: U.S. Senate Lobbying Disclosure Act database. Dollar figures (underlined) cite the filing record on lda.senate.gov — click to view the citation. Amounts shown as “not reported” are absent from the filing itself.